EDAP TMS S.A. - AMERIC

EDAP Announces Second Quarter 2023 Financial Results

24 авг 2023 06:30:00 Источник Nasdaq GlobeNewswire

EDAP TMS SA to Announce Second Quarter 2023 Financial Results on August 24, 2023  

10 авг 2023 08:00:00 Источник Nasdaq GlobeNewswire

EDAP Announces Reimbursement Approval in Switzerland for the Use of High-Intensity Focused Ultrasound (HIFU) in the Treatment of Prostate Cancer

26 июл 2023 08:00:00 Источник Nasdaq GlobeNewswire

EDAP to Present at the Jefferies Healthcare Conference

24 май 2023 08:00:00 Источник Nasdaq GlobeNewswire

EDAP Announces First Quarter 2023 Financial Results

17 май 2023 06:30:00 Источник Nasdaq GlobeNewswire

EDAP to Announce First Quarter 2023 Financial Results on May 17, 2023  

03 май 2023 08:00:00 Источник Nasdaq GlobeNewswire

EDAP Announces Major Presence at Upcoming Annual Meeting of the American Urological Association (AUA)

21 апр 2023 08:00:00 Источник Nasdaq GlobeNewswire

EDAP Announces Live Procedure Broadcast of Focal One High Intensity Focused Ultrasound (HIFU) to Global Clinical Audience

10 апр 2023 08:00:00 Источник Nasdaq GlobeNewswire

EDAP Announces Regulatory Clearance of ExactVu Micro-Ultrasound in Japan

06 апр 2023 08:00:00 Источник Nasdaq GlobeNewswire

EDAP Reports Record Fourth Quarter and Full-Year 2022 Results and Announces Leadership Succession Plan to Develop Global Group Strategy

30 мар 2023 06:30:00 Источник Nasdaq GlobeNewswire

EDAP Presents Positive Results from Non-Inferiority Study Comparing Outcomes of Focal One HIFU Versus Radical Prostatectomy at EAU23

21 мар 2023 16:30:00 Источник Nasdaq GlobeNewswire

EDAP to Announce Fourth Quarter and Full-Year 2022 Financial Results on Thursday, March 30th

09 мар 2023 08:00:00 Источник Nasdaq GlobeNewswire

EDAP Announces Record Preliminary Fourth Quarter and Full-Year 2022 Revenue

14 фев 2023 09:00:00 Источник Nasdaq GlobeNewswire

EDAP Announces Positive Results from Phase 2 Study Evaluating Therapeutic High-Intensity Focused Ultrasound (HIFU) for the Treatment of Rectal Endometriosis

31 янв 2023 08:00:00 Источник Nasdaq GlobeNewswire

EDAP Announces Record Q4 US Focal One Placements

05 янв 2023 08:00:00 Источник Nasdaq GlobeNewswire

EDAP Appoints Medical Capital Equipment Finance Veteran Ken Mobeck as Chief Financial Officer of Company’s U.S. Subsidiary

06 дек 2022 08:00:00 Источник Nasdaq GlobeNewswire

EDAP Announces Approval to Initiate Randomized Clinical Trial Evaluating Focal One® as a Potential Treatment for Rectal Deep Infiltrating Endometriosis

30 ноя 2022 16:01:00 Источник Nasdaq GlobeNewswire

EDAP to Present at the Piper Sandler 34th Annual Healthcare Conference

21 ноя 2022 08:00:00 Источник Nasdaq GlobeNewswire

EDAP Reports Third Quarter 2022 Results

16 ноя 2022 16:35:00 Источник Nasdaq GlobeNewswire

EDAP TMS SA to Announce Third Quarter 2022 Financial Results on Wednesday, November 16th, 2022

02 ноя 2022 08:00:00 Источник Nasdaq GlobeNewswire